PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021
In Poland there are still nearly 20 million individuals with hypercholesterolaemia, most of them are unaware of their condition; that is also why only ca. 5% of patients with familial hypercholesterolaemia have been diagnosed; that is why other rare cholesterol metabolism disorders are so rarely dia...
Main Authors: | Maciej Banach, Paweł Burchardt, Krzysztof Chlebus, Piotr Dobrowolski, Dariusz Dudek, Krzysztof Dyrbuś, Mariusz Gąsior, Piotr Jankowski, Jacek Jóźwiak, Longina Kłosiewicz-Latoszek, Irina Kowalska, Maciej Małecki, Aleksander Prejbisz, Michał Rakowski, Jacek Rysz, Bogdan Solnica, Dariusz Sitkiewicz, Grażyna Sygitowicz, Grażyna Sypniewska, Tomasz Tomasik, Adam Windak, Dorota Zozulińska-Ziółkiewicz, Barbara Cybulska |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2021-11-01
|
Series: | Archives of Medical Science |
Subjects: | |
Online Access: | https://www.archivesofmedicalscience.com/PoLA-CFPiP-PCS-PSLD-PSD-PSH-guidelines-on-diagnosis-and-therapy-of-lipid-disorders,141941,0,2.html |
Similar Items
-
Involvement of circRNAs in the Development of Heart Failure
by: Grażyna Sygitowicz, et al.
Published: (2022-11-01) -
The Diagnostic and Therapeutic Potential of Galectin-3 in Cardiovascular Diseases
by: Grażyna Sygitowicz, et al.
Published: (2021-12-01) -
A Review of the Molecular Mechanisms Underlying Cardiac Fibrosis and Atrial Fibrillation
by: Grażyna Sygitowicz, et al.
Published: (2021-09-01) -
Intensive Statin Therapy Versus Upfront Combination Therapy of Statin and Ezetimibe in Patients With Acute Coronary Syndrome: A Propensity Score Matching Analysis Based on the PL‐ACS Data
by: Joanna Lewek, et al.
Published: (2023-09-01) -
The Role of Galectin-3 in Heart Failure—The Diagnostic, Prognostic and Therapeutic Potential—Where Do We Stand?
by: Beata Zaborska, et al.
Published: (2023-08-01)